Patents by Inventor Anthony W. Czarnik

Anthony W. Czarnik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160137959
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Application
    Filed: May 31, 2015
    Publication date: May 19, 2016
    Inventors: Anthony W. Czarnik, Jeffrey A. McKinney
  • Patent number: 9179670
    Abstract: The present invention generally relates to deuterium-enriched aldehydes, compositions comprising deuterium-enriched aldehydes, and methods for slowing the rate of aldehyde autoxidation. In one aspect, the present invention provides a composition comprising a compound of structure 1: wherein: there are at least 6×1018 molecules of the aldehyde and Rx is hydrogen, wherein the deuterium isotope in Rx is in an amount greater than 0.10 percent of the hydrogen atoms present in Rx.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: November 10, 2015
    Assignee: Deuteria Agrochemicals, LLC
    Inventor: Anthony W Czarnik
  • Publication number: 20150292006
    Abstract: The invention relates to compositions and methods for multiplex decoding of microsphere array sensors.
    Type: Application
    Filed: July 2, 2014
    Publication date: October 15, 2015
    Inventors: Mark S. Chee, John R. Stuelpnagel, Anthony W. Czarnik
  • Publication number: 20150208651
    Abstract: The present invention generally relates to deuterium-enriched aldehydes, compositions comprising deuterium-enriched aldehydes, and methods for slowing the rate of aldehyde autoxidation. In one aspect, the present invention provides a composition comprising a compound of structure 1: wherein: there are at least 6×1018 molecules of the aldehyde and Rx is hydrogen, wherein the deuterium isotope in Rx is in an amount greater than 0.10 percent of the hydrogen atoms present in Rx.
    Type: Application
    Filed: April 7, 2015
    Publication date: July 30, 2015
    Inventor: Anthony W. Czarnik
  • Patent number: 9044423
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Grant
    Filed: January 13, 2014
    Date of Patent: June 2, 2015
    Assignee: Deuteria Beverages, LLC
    Inventors: Anthony W Czarnik, Jeffrey A McKinney
  • Patent number: 9023868
    Abstract: The present application describes deuterium-enriched lenalidomide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: January 24, 2014
    Date of Patent: May 5, 2015
    Assignee: Deuteria Pharmaceuticals, Inc.
    Inventor: Anthony W. Czarnik
  • Patent number: 9023336
    Abstract: The present invention generally relates to deuterium-enriched aldehydes, compositions comprising deuterium-enriched aldehydes, and methods for slowing the rate of aldehyde autoxidation. In one aspect, the present invention provides a composition comprising a compound of structure 1: wherein: there are at least 6×1018 molecules of the aldehyde and Rx is hydrogen, wherein the deuterium isotope in Rx is in an amount greater than 0.10 percent of the hydrogen atoms present in Rx.
    Type: Grant
    Filed: March 15, 2014
    Date of Patent: May 5, 2015
    Assignee: Deuterra Agrochemicals, LLC
    Inventor: Anthony W Czarnik
  • Publication number: 20150011651
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Application
    Filed: January 13, 2014
    Publication date: January 8, 2015
    Applicant: PROTIA, LLC
    Inventors: Anthony W. Czarnik, Jeffrey A. McKinney
  • Publication number: 20140329851
    Abstract: The present application describes deuterium-enriched prasugrel, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: February 7, 2014
    Publication date: November 6, 2014
    Applicant: DEUTERX, LLC
    Inventor: Anthony W. Czarnik
  • Publication number: 20140271537
    Abstract: The present invention generally relates to deuterium-enriched aldehydes, compositions comprising deuterium-enriched aldehydes, and methods for slowing the rate of aldehyde autoxidation. In one aspect, the present invention provides a composition comprising a compound of structure 1: wherein: there are at least 6×1018 molecules of the aldehyde and Rx is hydrogen, wherein the deuterium isotope in Rx is in an amount greater than 0.10 percent of the hydrogen atoms present in Rx.
    Type: Application
    Filed: March 15, 2014
    Publication date: September 18, 2014
    Inventor: Anthony W. Czarnik
  • Publication number: 20140243377
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: May 8, 2014
    Publication date: August 28, 2014
    Applicant: DEUTERX, LLC
    Inventor: Anthony W. Czarnik
  • Patent number: 8795967
    Abstract: The invention relates to compositions and methods for multiplex decoding of microsphere array sensors.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: August 5, 2014
    Assignee: Illumina, Inc
    Inventors: Mark S. Chee, John R. Stuelpnagel, Anthony W. Czarnik
  • Patent number: 8735454
    Abstract: The present application describes deuterium-enriched bupropion, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: August 22, 2013
    Date of Patent: May 27, 2014
    Assignee: DeuteRx, LLC
    Inventor: Anthony W. Czarnik
  • Publication number: 20140142141
    Abstract: The present application describes deuterium-enriched lenalidomide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: January 24, 2014
    Publication date: May 22, 2014
    Applicant: DEUTERIA PHARMACEUTICALS, INC.
    Inventor: Anthony W. CZARNIK
  • Patent number: 8722710
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: May 13, 2014
    Assignee: DeuteRx, LLC
    Inventor: Anthony W Czarnik
  • Patent number: 8669268
    Abstract: The present application describes deuterium-enriched prasugrel, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: March 11, 2014
    Assignee: DeuteRx, LLC
    Inventor: Anthony W Czarnik
  • Patent number: 8669275
    Abstract: The present application describes deuterium-enriched donepezil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: October 3, 2012
    Date of Patent: March 11, 2014
    Assignee: DeuteRx, LLC
    Inventor: Anthony W. Czarnik
  • Patent number: 8669276
    Abstract: The present application describes deuterium-enriched lenalidomide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: September 9, 2012
    Date of Patent: March 11, 2014
    Assignee: Deuteria Pharmaceuticals, Inc.
    Inventor: Anthony W. Czarnik
  • Patent number: 8658236
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Grant
    Filed: May 10, 2010
    Date of Patent: February 25, 2014
    Assignee: Deuteria Beverages, LLC
    Inventors: Anthony W Czarnik, Jeffrey A McKinney
  • Publication number: 20140018436
    Abstract: The present application describes deuterium-enriched bupropion, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2013
    Publication date: January 16, 2014
    Applicant: DEUTERX, LLC
    Inventor: Anthony W. Czarnik